The global anatomic pathology market is projected to grow at a CAGR of nearly 8% during the forecast period. Market expansion is primarily driven by the growing incidence of cancer and chronic ...

The round was led by FCA Venture Partners, with the Labcorp Venture Fund and Epsilon anchoring the final close as the primary investors. Strong participation also came from existing investors, ...

Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting ...

Labcorp Holdings Inc. (LH) has disclosed a new risk, in the Regulation category. Labcorp Holdings Inc. has reported that there have been no ...

The company's presence highlights Dublin’s growing reputation as a destination for innovation, connectivity and business ...

The Dublin-based firm is developing an array of artificial intelligence-derived tools to improve the efficiency of its digital pathology outsourcing service.

Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Labcorp Holdings yesterday and set a price target of $280.00. The company’s shares closed yesterday at $248.14. Take advantage of ...

Labcorp Holdings Inc (LH) reports a robust 9% revenue increase and a 19% rise in adjusted EPS, while navigating challenges in ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a ...